CD8A and neoplasm: Given the significant impact of 3′tiRNA-AlaCGC upregulation in tumor cells on CD8+ T cell functionality, we further investigated whether 3′tiRNA-AlaCGC expression in tumor cells could impair CD8+ T cell cytotoxicity and immunotherapy responsiveness in vivo (Fig. 7A).